Company Filing History:
Years Active: 2005
Title: Robert P. Hebbel: Innovator in Transgenic Endothelial Cells
Introduction
Robert P. Hebbel is a distinguished inventor based in North Oaks, Minnesota. He is known for his significant contributions to the field of biomedical engineering, particularly in the development of transgenic endothelial cells. His innovative work has the potential to enhance the biocompatibility of medical devices and advance gene therapy techniques.
Latest Patents
Hebbel holds a patent for a process that expands the population of endothelial cells obtained from peripheral blood. This process involves transforming these cells with a vector that contains a DNA sequence encoding a preselected bioactive polypeptide. The resulting transgenic endothelial cells are not only useful for biocompatibilizing implantable medical devices but can also be utilized directly in gene therapy applications. He has 1 patent to his name.
Career Highlights
Hebbel is affiliated with the University of Minnesota, where he continues to push the boundaries of research in endothelial cell biology. His work has garnered attention for its innovative approach to solving complex medical challenges.
Collaborations
Hebbel has collaborated with notable colleagues, including Yi Lin and John S. Lollar, to further advance his research and its applications in the medical field.
Conclusion
Robert P. Hebbel's contributions to the field of transgenic endothelial cells exemplify the impact of innovation in medicine. His work not only enhances the understanding of endothelial biology but also paves the way for future advancements in medical technology.